Verastem Oncology Strengthens Executive Leadership Team with Key Appointments

Mike Crowther Appointed Chief Commercial and Business Strategy Officer


David Mitchell Appointed Senior Vice President, Head of Regulatory Affairs


Dan Calkins Promoted to Chief Financial Officer...

Related Keywords

Mississippi ,United States ,Northeastern University ,Massachusetts ,Manchester ,United Kingdom ,Boston ,Dan Calkins ,Mike Crowther ,Dan Paterson ,David Mitchell ,Chugai Pharmaceutical Co Ltd ,Exchange Commission ,Ms College In Clinton ,Head Of Regulatory Affairs ,Johns Hopkins University ,European Medicines Agency ,Bryant University ,Secura Bio Inc ,Aquinox Pharmaceuticals ,Drug Administration ,Amgen ,Roivant Sciences ,Aeglea Pharmaceuticals ,Regulatory Affairs In Oncology At Abbvie ,Head Of Regulatory Affairs At Sumitovant Biopharma ,Manchester Metropolitan University In ,Company Annual Report On Form ,Raf And Mek Program ,Verastem Oncology ,Chief Executive Officer ,Chief Commercial ,Business Strategy Officer ,Chief Business Officer ,Minerva Biotechnologies ,Vice President ,Kite Pharma ,Global Marketing ,Manchester Metropolitan University ,Senior Vice President ,Regulatory Affairs ,Global Regulatory Lead ,New Drug ,Drug Applications ,Biologic License Applications ,Regulatory Science ,Chief Financial Officer ,Technical Accounting Consultant ,Breakthrough Therapy ,Secura Bio ,Annual Report ,Markets ,